Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia. Leukemia & lymphoma Yurkiewicz, I. R., Coutre, S., Ghesquieres, H., Pastan, I., Kreitman, R. J. 2021: 1-3

View details for DOI 10.1080/10428194.2021.1929959

View details for PubMedID 34030585